| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |